Businessman and philanthropist Andrew Barnes is donating £10 million to the University to establish the Charlotte Lockhart Precision Breast Cancer Institute, named after his beloved partner, who has terminal breast cancer.
Advancing patient care by combining breakthrough science from the University of Cambridge with AstraZeneca’s drug development capabilities.
In 1994, a landmark paper identified a gene – BRCA1 – that significantly increases the risk of breast and ovarian cancers when faulty. Thirty years on, we look at the major impact it has had on how we understand and treat cancer – and why there is still much to learn.
Find out about groundbreaking cancer research at Cambridge, including our planned new hospital, how we're studying the earliest stages of cancer, how AI is helping fight the disease, and the patients playing a key role in our work.
Two-thirds of the public say they are very or somewhat worried about being told they have cancer – higher than for any other medical condition – according to polling released today.
What excites Steve Jackson is understanding how biology works and why it sometimes goes wrong. But what galvanises him is knowing there are people alive today as a result of his discovery of how to create a cancer drug.
Leaders in fields from economics to history are among the Cambridge academics recognised in the King's first birthday honours list.
Learn the secrets of their success, what it takes to start a business or social venture and why Cambridge is a great place to try something new.
Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.
A leading pioneer in the field of protein engineering, Sir Alan Fersht FMedSci FRS, has been named as the 2020 winner of the world’s oldest scientific prize, the Royal Society’s prestigious Copley Medal.
© 2026 University of Cambridge